...
首页> 外文期刊>Oncology letters >Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonates
【24h】

Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonates

机译:骨水泥充填内固定及口服双膦酸盐治疗骨巨细胞瘤的临床结果

获取原文
获取原文并翻译 | 示例

摘要

Giant cell tumor (GCT) of the bone is a relatively common primary bone tumor. Treatment with simple curettage often results in a high local recurrence rate. Tumor resection and reconstruction with prosthesis or an allograft has a low rate of local recurrence; however, the patient's native joint function becomes significantly impaired. With the development and usage of aggressive curettage, it is a priority to treat GCT with a method that reduces the local recurrence rate and preserves the native joint. To evaluate the feasibility of treating GCT with aggressive curettage and cement filling using internal fixation and oral bisphosphonates, 16 patients with GCT of the bone located in the distal femur and treated in our department from January 2008 to June 2011, were followed up. The patients had received aggressive curettage, bone cement filling, internal fixation and oral administration of bisphosphonates. There were seven males and nine females in total, with a mean age of 38 years. All patients were carefully assessed prior to surgery in order to determine the integrity of the tumor cavity. Subsequently, patients were treated with aggressive curettage by high-speed burring and cementation with internal fixation, and were administered postoperative oral alendronate sodium tablets (10 mg/day) for two years. The median follow-up time was 25 months. None of the patients were lost to follow-up. No local recurrence or metastasis was observed in the last follow-up. The Enneking limb function score range of the affected limb was 24-29 (average, 26.7). At the last follow-up, all patients exhibited solid fixation without fracture of the subchondral bone in plain radiographs. Based on these data, we suggest that patients with distal femoral GCT may be treated with aggressive curettage and cement filling, with internal fixation and oral bisphosphonates. The advantages of this method are its safety and efficacy. However, the long-term outcomes require further investigation.
机译:骨的巨细胞瘤(GCT)是一种相对常见的原发性骨肿瘤。单纯刮宫治疗通常会导致较高的局部复发率。用假体或同种异体移植物进行肿瘤切除和重建的局部复发率低;但是,患者的天然关节功能明显受损。随着积极刮除术的发展和使用,使用降低局部复发率并保留天然关节的方法来治疗GCT是当务之急。为了评估采用积极的刮除术和使用内固定和口服双膦酸盐充填水泥治疗GCT的可行性,我们对2008年1月至2011年6月在我院接受治疗的16例股骨远端骨GCT患者进行了随访。患者接受了积极的刮除术,骨水泥充填,内固定和双膦酸盐口服。一共有七名男性和九名女性,平均年龄为38岁。所有患者在手术前均经过仔细评估,以确定肿瘤腔的完整性。随后,通过高速去毛刺和内固定固定术对患者进行积极的刮除术,并给予术后口服阿仑膦酸钠钠片(10毫克/天),为期两年。中位随访时间为25个月。没有患者失去随访。在最后一次随访中未观察到局部复发或转移。受累肢体的Enneking肢体功能评分范围为24-29(平均26.7)。在最后一次随访中,所有患者均表现出牢固的固定,而X线平片未显示软骨下骨骨折。根据这些数据,我们建议股骨远端GCT患者可以采用积极的刮除术和骨水泥充填术,内固定术和口服双膦酸盐治疗。该方法的优点是其安全性和有效性。但是,长期结果需要进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号